• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION CHARGER; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION CHARGER; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL Back to Search Results
Model Number 24681
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/23/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that balloon rupture occurred.The 70-80% stenosed target lesion was located in the non-tortuous and mildly calcified vessel.A 10.0 x40, 75cm charger balloon catheter was prepared and advanced for transjugular intrahepatic portosystemic shunt revision procedure.However, the balloon ruptured upon initial inflation at 10 atmospheres for 15 seconds.The device was removed without any fragments left in the patient, and the procedure was completed with another charger balloon.No complications were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: the device was returned for analysis.A visual examination identified that the balloon was not folded which indicates that the balloon was subjected to positive pressure.A balloon longitudinal tear was identified, beginning approximately 7mm distal of the distal markerband and extending approximately 25mm proximally across the balloon material.The rated burst pressure for this device as per specification.A visual and tactile examination found no kinks or damage to the shaft or to the tip of the device.A visual examination observed no issues with the markerbands of the device.Both markerbands were undamaged in the correct position on the device.
 
Event or Problem Description
It was reported that balloon rupture occurred.The 70-80% stenosed target lesion was located in the non-tortuous and mildly calcified vessel.A 10.0 x40, 75cm charger balloon catheter was prepared and advanced for transjugular intrahepatic portosystemic shunt revision procedure.However, the balloon ruptured upon initial inflation at 10 atmospheres for 15 seconds.The device was removed without any fragments left in the patient, and the procedure was completed with another charger balloon.No complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CHARGER
Common Device Name
CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
pmt 741 persiaran cassia selat
bandarcassia, pulau pinan 14110
MY   14110
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key20242960
Report Number2124215-2024-58146
Device Sequence Number7363201
Product Code FGE
UDI-Device Identifier08714729803799
UDI-Public08714729803799
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K112697
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/09/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number24681
Device Catalogue Number24681
Device Lot Number0033166666
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/16/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/26/2024
Supplement Date Received by Manufacturer09/18/2024
Initial Report FDA Received Date09/17/2024
Supplement Report FDA Received Date10/09/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/10/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-